Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions
Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions have?
Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions has 65 citations in the OpenAlex counts ScholarIQ stores.
When was Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions published?
Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions has 2018 year in the ScholarIQ index.
What is the open-access status of Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions?
Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions has gold oa status in the ScholarIQ index.
What is the DOI of Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions?
The DOI for Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions is on the source record.
What is the PMID of Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions?
The PMID for Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions is on the source record.
What is the OpenAlex record for Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions?
The OpenAlex for Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions is on the source record.